• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Egyptian Journal of Community Medicine
Articles in Press
Current Issue
Journal Archive
Volume Volume 37 (2019)
Volume Volume 36 (2018)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 35 (2017)
Volume Volume 34 (2016)
Volume Volume 33 (2015)
(2018). The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon. The Egyptian Journal of Community Medicine, 36(3), 93-102. doi: 10.21608/ejcm.2018.16337
. "The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon". The Egyptian Journal of Community Medicine, 36, 3, 2018, 93-102. doi: 10.21608/ejcm.2018.16337
(2018). 'The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon', The Egyptian Journal of Community Medicine, 36(3), pp. 93-102. doi: 10.21608/ejcm.2018.16337
The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon. The Egyptian Journal of Community Medicine, 2018; 36(3): 93-102. doi: 10.21608/ejcm.2018.16337

The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon

Article 9, Volume 36, Issue 3, Summer 2018, Page 93-102  XML PDF (348.66 K)
Document Type: Original Article
DOI: 10.21608/ejcm.2018.16337
Abstract
Background: Cancer colon is one of most common cancers worldwide. Colonoscopy; an
invasive and costly investigation method is the most reliable tool for diagnosis. Early
diagnosis of cancer colon gives a high chance of cure. Fecal M2-PK; a tumor biomarker is
a new approach for cancer colon screening. Objective: This study aimed to evaluate fecal
M2-PK as a biomarker for cancer colon screening. Methods: This comparative crosssectional
study included 3 groups: 30 healthy individuals (Group Ι), 50 diagnosed cancer
colon patients (Group П) and 20 cancer colon patients who were the only operable patient
from Group П (Group III). For all groups, history and physical examination was done.
Fecal M2-PK concentrations were detected by ELISA. Results: The study revealed that
there was a significant difference between cancer colon patients and healthy individuals
(control) regarding age (p=0.046*), BMI (p=0.004*), history of smoking (p=0.025*),
history of low fiber and high protein diet (p=0.001*), and levels of M2-PK (p=0.001*).
There was a significant difference in the mean value of M2PK levels in relation to sex
(p=0.043*) and site of cancer colon (p=0.002*) only. Cancer colon can be detected with
fecal M2-PK with remarkable sensitivity &specificity (98% and 93% respectively). The
overall accuracy of M2PK in detecting cancer colon was 96.6%. Conclusion: Fecal M2-
PK is considered as a good screening biomarker for cancer colon.
Keywords
Cancer Colon; M2-PK; biomarker
Statistics
Article View: 380
PDF Download: 279
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.